Abstract. Kaempferia parviflora (KP) extract has been used in the Thai medicinal plant recipe, which the methoxyflavones are the main active compound. These compounds have low water solubility, high lipophilicity, and low bioavailability. The aim of this study was to develop the pluronic lecithin organogel (PLO) and PLO with d-limonene (PLO-L) for enhancing transdermal delivery of KP extract. These formulations were prepared and their physicochemical properties, stability, and in vitro skin permeation were evaluated. For the result, all formulations exhibited good physicochemical properties and stable under storage condition for 3 months. The permeation of KP extract-loaded PLO-L and PLO formulation showed significantly higher total methoxyflavones permeated through the skin than KP extract in water, which PLO-L provided the highest permeated flux of total methoxyflavones. This result suggested that d-limonene play a role as skin permeation enhancer. Organogel consisting of poloxamer 407 and lecithin also increased the skin permeation of KP extract. In conclusion, PLO-L could be a potential transdermal delivery system for KP extract.
Introduction
Kaempferia parviflora (KP) that is commonly known as "krachaidum", or "black ginger", was previously demonstrated to have a number of physiological effects, including male sexual enhancement, antimicrobial, aphrodisiac effect, antigastric ulcer, antidepressant, anticholinesterase activity, anti-obesity effects, vasodilator and antioxidant effects [1] . The main active ingredient of KP extract is the methoxyflovone derivative, which 5,7-dimethoxyflavone (DMF), 5,7,4'-trimethoxyflavone (TMF), and 3,5,7,3', 4'-pentamethoxyflavone (PMF) are commonly found. These compounds have low water solubility, high lipophilicity, and low bioavailability (about 1-4%) [2] [3] [4] . Therefore, a potential transdermal delivery system should be developed to increase KP into the body and improve its therapeutic effects.
Organogel is a thermodynamically stable semisolid system, which an organic liquid phase is immobilized by a three-dimensional network of a gelator [5] . It has also been used as a potential transdermal drug delivery system. In recent years, organogel consisting of an aqueous solution of pluronic F127™ (poloxamer 407) and lecithin have been reported to facilitate hydrophilic and lipophilic drugs through the skin [6, 7] .
The aim of the study was to develop the pluronic lecithin organogel formulations for enhancing transdermal delivery of KP extract. These formulations were prepared and their physicochemical properties, stability, and in vitro skin permeation were investigated.
Materials and methods

Materials
Isopropyl palmitate (IPM) was purchased from Nikkol, Singapore. Oleic acid and d-limonene were obtained from Sigma Aldrich, MO, USA. Lecithin (Emulmetik ® 900) was purchased from Lucas Meyer Cosmetics, France. Poloxamer 407 (Kolliphor ® P 407) was obtained from BASF Corporation, Germany.
For KP extract, the dried rhizomes were purchased from Loei province, Thailand. The percolation technique with ethanol was employed to extract the methoxy flavones from KP.
Preparation of KP extract-loaded pluronic lecithin organogel (PLO)
PLO formulation containing oil phase (5%w/w IPM, and 5%w/w oleic acid dissolved in 10%w/w lecithin) and aqueous phase (20%w/w Poloxamer 407 dissolved in cold water) was prepared. For PLO-L formulation, 5%w/w d-limonene was added into 10%w/w KP extract. Then, KP extract, oil phase, and the aqueous phase were mixed at ambient temperature.
Physicochemical properties
The pH value was evaluated using a pH meter (Metler Toledo, Seven compact S220) at room temperature. For viscosity measurement, the samples were measured using a Brookfield viscometer (DV-III ultra, Brookfield Engineering Laboratories, USA) at 25 °C. The stability of the formulations were monitored for 3 months under long-term (at room temperature) and accelerated (40 + 2 °C, 75 + 5 %RH) conditions. The quantities of total methoxyflavones remaining in the formulations were determined at the beginning and after 3 months. Each experiment was determined in triplicate.
In vitro skin permeation study
Abdominal skin was obtained from naturally dead newborn pig from a farm in Ratchaburi province, Thailand. The subcutaneous layer was separated by medical scissors and surgical blades (thickness 0.6-0.7 mm). Each skin was placed between donor and receiver compartment of Franz-type diffusion cells. Approximately 6 ml of phosphate buffer saline (PBS, pH 7.4) was filled in the receiver part and stirred by a magnetic bar at 32 °C. The 1 g of each formulation was added into the donor compartment. At 15, 30 min, 1, 2, 4, 8 and 24 h, 0.8 mL of the receiver fluid was withdrawn, and fresh PBS was added to keep the constant volume of the receiver medium. The KP content was analyzed using a UPLC.
The cumulative amounts of total methoxyflavones permeated across the skin vs time were plotted, and the slope of each line represents a permeated flux. The permeability coefficients (Kp) were calculated from the cumulative skin permeation profile using the flux, and the donor concentration (Cd) of the formulations by equations (1) . Kp = Flux/Cd (1)
UPLC analysis
Three methoxyflavones (DMF, TMF and PMF) were analyzed using an ACQUITY UPLC Core system (Waters Corporation, Milford, USA) binary solvent management and dual switching solvent/Degas/ ACQUITY TUV Detector and column heater. ACQUITY UPLC BEC C18 column (2.1 mm x 100 mm, 1.7 µm, Waters ® ) was used. The mobile phase consisted of acetonitrile and 0.5% formic acid in water (15:85 to 85:15), with the flow rate of 0.5 ml/min and 2.0 µL injection volume. The operating temperature of column and samples was controlled at 38 and 25 °C, respectively. The detection was operated using a UV detector at 335 nm. The linearity range was 0.001-35 µg/ml and the R 2 of the mean calibration plot was 0.9999.
Data analysis
Each experiment was measured in triplicate. The results were reported as mean + standard deviation (SD). The statistically significant differences between formulations were determined using analysis of variance (ANOVA) with an LSD post hoc test. The significance level was set at p < 0.05.
Results and discussion
Physicochemical properties
The amounts of DMF, PMF and TMF in KP extract were 10.39, 9.18, and 10.13%, respectively. All formulations containing 10%w/w of KP extract were successfully prepared and exhibited brown opaque gel with pH 4.66. The percent total methoxyflavones content of PLO and PLO-L were 99.44 + 1.28 % and 99.37 + 2.07 %, respectively. The viscosity of PLO and PLO-L were 42,256.96 + 771.47 cP and 35,513.29 + 561.49 cP, respectively.
As shown in Fig. 1 , the physicochemical properties of PLO-L formulation under storage conditions for 3 months exhibited a little change from the initial day of preparation, representing good formulation stability. 
In vitro skin permeation study
As shown in Fig. 2 , the permeation of KP extractloaded PLO-L and PLO formulation showed significantly higher total methoxyflavones permeated through the skin than KP extract in water, which the permeated flux and permeability coefficient were in the order: PLO-L > PLO > KP extract in water (Table 1) . PLO-L provided the highest permeated flux of total methoxyflavones that was 2.00-fold enhancement from KP extract. This result indicated that d-limonene play a role as skin permeation enhancer and intercalate into stratum corneum intercellular lipids, leading to increase lipid lamellae fluidity and enhance skin permeability of drug via an intercellular pathway [8] . For PLO formulation that also enhanced total methoxyflavones permeability. Lecithin organogels might be efficient carriers for transdermal delivery, because lecithin promoted the skin permeation and partitioning of the drug into the skin layers. In addition, pluronic lecithin organogel is known as a new lecithin organogel. These systems have been developed for improving the skin permeation and stabilizing the formulation [9, 10] . Poloxamer 407 is a copolymer of polyoxyethylene and polyoxypropylene, which it can form a thermoreversible gel [11] and disrupts lipid layers of the skin stratum corneum [12] . Moreover, the PLO system has both oil and aqueous phases, so this system might be a potential transdermal delivery system of hydrophilic as well as lipophilic drugs [6, 7] .
Conclusion
In this study, pluronic lecithin organogel consisting d-limonene could be a potential transdermal delivery system for KP extract. This system provided the highest skin permeability of total methoxylflavone and suitable physicochemical properties with good stability under long-term and accelerated condition.
